Gc college university, Public university in Toronto, Ontario

A new study by researchers at the University of Toronto has identified hundreds of new proteins that could play a role in cystic fibrosis, and which may shed light on why some patients responded better than others to current therapies.The findings were published in the journal, 'Molecular Systems Biology'.Many of these proteins -- part of a group of druggable molecules called membrane proteins -- interacted with the CFTR protein, which when missing or faulty led to the build-up of mucous in the lungs and other organs that was often fatal in cystic fibrosis."We identified more than 400 proteins associated with either healthy or mutant CFTR, and have shown that some of them could predict the variability seen in patient symptoms and treatment responses," said Igor Stagljar, principal investigator on the study and a professor in the Donnelly Centre for Cellular and Biomolecular Research at U of T's Temerty Faculty of Medicine."With a more comprehensive view of the CFTR protein interaction network, we can identify novel drug targets that should enable more patient-specific therapies," Stagljar said.To help identify protein-protein interactions involving CFTR, the researchers developed a new technology based on a platform they designed in 2014. The approach was a high-through-put version of their Mammalian Membrane Two-Hybrid system, and it allowed for screening of many more membrane proteins that associate with a specific protein."The earlier design was array-based, and we could only screen about 200 proteins at a time," said Stagljar, who is also a professor of biochemistry and molecular genetics at U of T. "With this new technology, we've introduced several changes that allow us to screen thousands of protein targets simultaneously, in a pooled manner."Stagljar and his lab used the technology to find several overlooked proteins, including many membrane proteins that may play a role in CFTR function and cystic fibrosis. Membrane proteins account for roughly one-third of all proteins in cells and about 65 per cent of all drug therapy targets.One especially promising candidate the team found is the Fibrinogen-like 2 protein, thought to play a role in hepatitis, liver disease and immune function. Down regulation of this protein, the team showed, leads to increased expression of CFTR in organoids -- 3D in vitro models that show how cells interact in an organ, in this case with patient-derived gut tissues."We think Fibrinogen-like 2 protein is a valuable drug target for cystic fibrosis, and we're now working with our collaborators to validate other proteins that turned up in this study and in genome-wide association studies," Stagljar said.Cystic fibrosis affects over 90,000 people globally. The disease arises when children inherit two mutated CFTR genes, one from each parent, resulting in defective CFTR proteins on the surface of cells in the lungs and other organs.About 2,000 known mutations of the CFTR gene can cause the disease, and drug treatments are often tailored based on each patient's genetic profile. Some of those treatments have shown remarkable success in the last decade by restoring the function of the CFTR protein. But treatment response can vary widely, even among patients who share the same mutation.Stagljar said that while researchers have long suspected that those variations in treatment response hinge on secondary genetic modifiers and environmental factors, the current study strongly suggests proteins that physically associate with CFTR are one of those factors.Two members of the Stagljar lab were co-first authors on the paper. Dr SangHyun Lim, a biochemistry doctoral student at the time of the study who is now a postdoctoral researcher at Genentech and senior research associate, Dr Jamie Snider.Stagljar said both were instrumental in the research, and show that the university continues to train and benefit from great research talent. Both worked closely with other labs on the project, in particular at U of T, The Hospital for Sick Children and the University of Lisboa in Portugal."This study represents a breakthrough in proteomics and cystic fibrosis, but it would have been impossible without our many collaborators," said Stagljar. "We developed the technology, but we're not experts in cystic fibrosis, physiology and other fields, so we teamed up with the best and they made it happen -- that's how science works nowadays."( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Gc College UniversityFOLLOW

Gc college university, Latest News

Toronto, July 18 Canadian researchers have grown a small-scale model of a human left heart ventricle - the ... ...

Toronto, June 7 An international team of scientists has released the largest near-infrared image ever taken by the ... ...

Lovely Professional University (LPU) is ranked among top 100 universities of the world by the internationally acclaimed, Times Higher Education (THE) Impact Rankings-2022. ...

According to a new study by the University of Toronto, adults exposed to chronic parental domestic violence have an elevated prevalence of depression, anxiety and substance abuse disorders, and lower levels of social support than their peers who do n ...

A new study has found that two in five adults (42 per cent) with attention deficit hyperactivity disorder (ADHD) were in excellent mental health. ...

A new study has found that two in five adults (42 per cent) with attention deficit hyperactivity disorder (ADHD) were in excellent mental health. ...

Toronto, April 9 Patients with kidney disease may have an increased risk of cancer and may be more ... ...

A new study by researchers at the University of Toronto has identified hundreds of new proteins that could play a role in cystic fibrosis, and which may shed light on why some patients responded better than others to current therapies. ...